ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,387Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 586

$504K Total Retail Price of All Prescriptions

Rank: 24 out of 586

438 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Utah
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 438 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

16% of this provider’s 438 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

3% of this provider’s 8,447 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Utah
LEVOTHYROXINE SODIUM 587 518 1 2
SIMVASTATIN 451 383 2 1
OMEPRAZOLE 417 346 3 3
FUROSEMIDE 322 261 4 9
POTASSIUM CHLORIDE 280 242 5 14
HYDROCODONE-ACETAMINOPHEN 275 200 S3 6 5
LISINOPRIL 250 225 7 4
TRAMADOL HCL 238 191 8 15
METFORMIN HCL 228 175 9 6
WARFARIN SODIUM 209 189 10 13
ZOLPIDEM TARTRATE 194 168 11 8
CITALOPRAM HBR 165 139 12 12
ATENOLOL 154 132 13 34
GABAPENTIN 152 115 14 11
BISOPROLOL-HYDROCHLOROTHIAZIDE 143 77 15 91
LOSARTAN POTASSIUM 142 111 16 18
HYDROCHLOROTHIAZIDE 137 135 17 10
AMLODIPINE BESYLATE 129 128 18 7
LISINOPRIL-HYDROCHLOROTHIAZIDE 120 95 19 16
FLUOXETINE HCL 118 88 20 24
METOPROLOL TARTRATE 118 112 20 26
MELOXICAM 116 108 22 25
ALLOPURINOL 107 103 23 35
METOPROLOL SUCCINATE 99 86 24 19
TAMSULOSIN HCL 97 97 25 27
CARVEDILOL 96 53 26 30
ALENDRONATE SODIUM 94 85 27 23
FLUTICASONE PROPIONATE 88 76 28 28
LYRICA 84 46 29 87
RANITIDINE HCL 77 58 30 61
SERTRALINE HCL 71 67 31 21
PREDNISONE 67 55 32 56
GLYBURIDE 66 46 R 33 101
PRAVASTATIN SODIUM 64 64 34 22
AZITHROMYCIN 63 56 35 36
PANTOPRAZOLE SODIUM 60 42 36 68
ATORVASTATIN CALCIUM 59 42 37 17
CLONIDINE HCL 56 44 38 113
DOXAZOSIN MESYLATE 54 39 39 94
CLOPIDOGREL 54 51 39 71
JANUVIA 52 39 41 74
OXYCODONE HCL-ACETAMINOPHEN 51 33 S2 42 55
OXYCODONE-ACETAMINOPHEN 51 35 S2 42 78
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 30, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.